This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.
Pre-Markets Rebound After Selloff; PCE & Q2 Numbers Everywhere
by Mark Vickery
Year over year PCE headline came down to +3.0%, +4.1% on core. Still above the Fed's optimum inflation rate, but well off cycle highs.
Core PCE Inflation Drops to 2 - Year Low
by Zacks Equity Research
Core PCE Inflation Drops to 2 - Year Low
Colgate-Palmolive (CL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.67% and 3.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Top-Rated Stocks to Watch as Earnings Approach
by Shaun Pruitt
Investors should pay attention to other sectors outside of Energy on Friday as there appears to be opportunity in these Consumer Staples and Auto sector stocks.
Should You Buy Colgate-Palmolive (CL) Ahead of Earnings?
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors to Note Ahead of Panasonic's (PCRFY) Q1 Earnings
by Zacks Equity Research
Amid macro-economic turmoil, Panasonic's (PCRFY) first-quarter fiscal 2024 performance is likely to have been cushioned by continued momentum in sales of A2W products in Europe.
Colgate (CL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.
Clorox (CLX) Gains From Digital Initiatives & Pricing Power
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy serves as a catalyst for driving innovation, enhancing operational efficiency and bolstering international growth.
Procter & Gamble (PG) Widens Spectrum on Value Creation
by Zacks Equity Research
Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.
3 Stocks to Buy for Decreased Volatility
by Derek Lewis
With CPI looming, investors may want to visit low-beta stocks as a shield against volatility. As we all know by now, CPI days have become quite a market-moving event.
Church & Dwight (CHD) Shares Up 21.9% YTD: What's Driving It?
by Zacks Equity Research
Church & Dwight (CHD) gains from its strength across end markets, acquired assets, its solid online channel and shareholder-friendly policies.
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Implied Volatility Surging for Colgate-Palmolive (CL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Soaps & Cleaning Materials Stocks to Gain in a Prospering Industry
by Rajani Lohia
The soap and cleaning materials industry is positioned to gain from revived demand trends, pricing actions, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, RBGLY, CHD and CLX look well-poised.
Colgate-Palmolive (CL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Colgate (CL) Rises 5% in the Past Three Months: Here's How
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Is Colgate-Palmolive (CL) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Zacks Analyst Blog Highlights McDonald's, Deere, Marsh & McLennan, Uber Technologies and Colgate-Palmolive
by Zacks Equity Research
McDonald's, Deere, Marsh & McLennan, Uber Technologies and Colgate-Palmolive are included in this Analyst Blog.
Top Stock Reports for McDonald's, Deere & Marsh & McLennan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Deere & Company (DE) and Marsh & McLennan Companies, Inc. (MMC).
Clorox (CLX) Beats Q3 Earnings & Sales Estimates, Ups View
by Zacks Equity Research
Clorox's (CLX) Q3 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.